首页|期刊导航|中国癌症杂志|靶向治疗及免疫治疗联合化疗为产AFP阳性结肠癌患者带来显著获益1例病例报告并文献复习

靶向治疗及免疫治疗联合化疗为产AFP阳性结肠癌患者带来显著获益1例病例报告并文献复习

LIU Miao LI Jinze WU Chensi ZHANG Fengbin GAO Hongsheng ZHANG Ruixing

中国癌症杂志2025，Vol.35Issue(12)：1154-1156,3.

中国癌症杂志2025，Vol.35Issue(12)：1154-1156,3.DOI:10.19401/j.cnki.1007-3639.2025.12.008

Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients:a case report and literature review

LIU Miao ¹LI Jinze ²WU Chensi ¹ZHANG Fengbin ¹GAO Hongsheng ¹ZHANG Ruixing¹

作者信息

1. Department of Gastroenterology,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050000,Hebei Province,China
2. Department of Pathology,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050000,Hebei Province,China
折叠

甲胎蛋白/结直肠癌/免疫治疗/靶向治疗/病例报告

Alpha fetoprotein/Colorectal cancer/Immunotherapy/Targeted therapy/Case report

医药卫生

LIU Miao,LI Jinze,WU Chensi,ZHANG Fengbin,GAO Hongsheng,ZHANG Ruixing..靶向治疗及免疫治疗联合化疗为产AFP阳性结肠癌患者带来显著获益1例病例报告并文献复习[J].中国癌症杂志,2025,35(12):1154-1156,3.

河北省卫生健康委员会医学科学研究课题计划项目(20250700). Medical Science Research Project of Hebei Provincial Health Commission(20250700). （20250700）

OA北大核心

ISSN：1007-3639

访问量0

下载量0

段落导航